EUVIMEDEUVIMED entdecken
Systematische Übersicht

Coumarin derivatives as anticancer agents targeting PI3K-AKT-mTOR pathway: a comprehensive literature review

Md Sakib Al Hasan, Yasin Emon, Mohammad Y Alshahrani, Md Mizan, Mohammed Burhan Uddin, Ali Mohamod Wasaf Hasan, Md Abu Sayeed, Emon Mia, Noshin Tasnim Yana, Rakib Hossan, Muhammad Torequl Islam

Medical Oncology · 30.06.2025 · 42 (8)

DOI: 10.1007/s12032-025-02844-9 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Medical Oncology, online erschienen am 30.06.2025. Verfasst von Md Sakib Al Hasan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, 8100, Bangladesh. mdsakibalhasan192412@gmail.com. Hauptthemen laut MEDLINE: Coumarins, TOR Serine-Threonine Kinases, Antineoplastic Agents, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 107 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coumarin is a natural benzopyrone compound known for its diverse pharmacological activities, including anticancer, anti-inflammatory, and antioxidant properties. But its derivatives' exploration in cancer, specially PI3K-AKT-mTOR pathways-based cancer activity not explored yet. This review aims to evaluate the anticancer potential of coumarin derivatives' by exploring their modulatory effects on the PI3K-AKT-mTOR signaling pathway across diverse cancer types. This review adopted a systematic literature approach, emphasizing studies across various cancer types and focusing on coumarin's mechanisms and therapeutic potential. Results reveal that coumarin derivatives suppress PI3K-AKT-mTOR pathway activity across cancers, such as liver, breast, and colorectal, with IC50 values ranging from 4 µM to > 200 µM in vitro and confirmed effects in vivo. The modulation of other pathways, including NF-κB and MAPK, underscores their multi-targeted anticancer action. Despite promising preclinical efficacy, challenges like low bioavailability, potential hepatotoxicity, and systemic toxicity persist. Structure-activity relationship (SAR) studies suggest that introducing specific functional groups can enhance selectivity, reduce toxicity, and improve therapeutic outcomes. The conclusion reinforces the potential of coumarin derivatives as novel anticancer agents, advocating for structural optimizations and clinical investigations to overcome pharmacokinetic barriers and maximize therapeutic benefits. This exploration offers a strategic perspective on utilizing coumarin-based molecules in advancing cancer therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoumarinsTOR Serine-Threonine KinasesAntineoplastic AgentsProto-Oncogene Proteins c-aktNeoplasmsHumansSignal TransductionPhosphatidylinositol 3-KinasesAnimals

Stichwörter der Autor:innen

CancerLiterature reviewPI3K-AKT-mTOR pathwayToxicological profile

Substanzen

CoumarinsTOR Serine-Threonine KinasesAntineoplastic AgentsProto-Oncogene Proteins c-aktMTOR protein, humanPhosphatidylinositol 3-Kinasescoumarin

Autor:innen und Institutionen

  • Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, 8100, Bangladesh. mdsakibalhasan192412@gmail.com.
  • Phytochemistry and Biodiversity Research Laboratory, BioLuster Research Center Ltd., Gopalganj, 8100, Bangladesh. mdsakibalhasan192412@gmail.com.
  • Department of Pharmacy, Islamic University, Kushtia, 7003, Bangladesh.
  • Central Labs, King Khalid University, P.O. Box 61413, 9088, Abha, Saudi Arabia.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, P.O. Box 61413, 9088, Abha, Saudi Arabia.
  • Department of Pharmacy, Dhaka International University, Satarkul, Badda, Dhaka-1212, Bangladesh.

Zitieren

APA

Al Hasan, M. S., Emon, Y., Alshahrani, M. Y., Mizan, M., Uddin, M. B., Hasan, A. M. W., Sayeed, M. A., Mia, E., Yana, N. T., Hossan, R., & Islam, M. T. (2025). Coumarin derivatives as anticancer agents targeting PI3K-AKT-mTOR pathway: a comprehensive literature review. Medical Oncology, 42(8). https://doi.org/10.1007/s12032-025-02844-9

Vancouver

Al Hasan MS, Emon Y, Alshahrani MY, Mizan M, Uddin MB, Hasan AMW, et al. Coumarin derivatives as anticancer agents targeting PI3K-AKT-mTOR pathway: a comprehensive literature review. Medical Oncology. 2025;42(8). doi:10.1007/s12032-025-02844-9

BibTeX
@article{AlHasan2025,
  author = {Al Hasan, Md Sakib and Emon, Yasin and Alshahrani, Mohammad Y and Mizan, Md and Uddin, Mohammed Burhan and Hasan, Ali Mohamod Wasaf and Sayeed, Md Abu and Mia, Emon and Yana, Noshin Tasnim and Hossan, Rakib and Islam, Muhammad Torequl},
  title = {Coumarin derivatives as anticancer agents targeting PI3K-AKT-mTOR pathway: a comprehensive literature review},
  journal = {Medical Oncology},
  year = {2025},
  volume = {42},
  number = {8},
  doi = {10.1007/s12032-025-02844-9}
}
Kostenlos starten →